Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1993 | 12-1992 | 12-1991 | 12-1990 | 12-1989 | |
| Sales | 380,061 | 315,165 | 230,035 | 158,732 | 115,962 |
| Cost of Goods | 140,233 | 116,532 | 81,836 | 60,339 | 51,399 |
| Gross Profit | 239,828 | 198,633 | 148,199 | 98,393 | 64,563 |
| Operating Expenses | 131,477 | 106,382 | 78,569 | 59,155 | 51,153 |
| Operating Income | 108,584 | 92,783 | 70,466 | 39,577 | 13,809 |
| Interest Expense | 2,084 | 2,846 | 2,894 | 4,578 | 5,756 |
| Other Income | 2,995 | 1,635 | 221 | 536 | -54 |
| Pre-tax Income | 109,495 | 91,572 | 67,793 | 35,535 | 7,999 |
| Income Tax | 39,810 | 34,927 | 26,337 | 12,056 | 2,737 |
| Net Income Continuous | 69,685 | 56,645 | 41,706 | 23,479 | 5,262 |
| Net Income Discontinuous | 0 | 0 | 250 | 423 | 941 |
| Net Income | $69,685 | $56,645 | $41,706 | $23,902 | $6,203 |
| EPS Basic Total Ops | 0.18 | 0.14 | 0.11 | 0.06 | 0.02 |
| EPS Basic Continuous Ops | 0.18 | 0.14 | 0.11 | 0.06 | 0.01 |
| EPS Diluted Total Ops | 0.18 | 0.14 | 0.11 | 0.06 | 0.02 |
| EPS Diluted Continuous Ops | 0.18 | 0.14 | 0.11 | 0.06 | 0.01 |
| EBITDA(a) | $114,949 | $97,372 | $73,889 | $42,005 | $16,027 |